Provided by Tiger Trade Technology Pte. Ltd.

Dare Bioscience

1.55
+0.04002.65%
Pre-market: 1.570.0171+1.10%04:46 EDT
Volume:266.78K
Turnover:408.64K
Market Cap:22.57M
PE:-1.29
High:1.60
Open:1.55
Low:1.49
Close:1.51
52wk High:9.19
52wk Low:1.27
Shares:14.56M
Float Shares:13.31M
Volume Ratio:2.36
T/O Rate:2.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2000
EPS(LYR):-0.4770
ROE:-2543.13%
ROA:-31.04%
PB:7.94
PE(LYR):-3.25

Loading ...

Mar 08, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Major Issues Report

8-K - Current report
Jan 11, 2021

Major Issues Report

8-K - Current report
Jan 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 05, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jan 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 23, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 22, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Dec 09, 2020

Major Issues Report

8-K - Current report
Dec 07, 2020

Major Issues Report

8-K - Current report
Nov 18, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 06, 2020

Major Issues Report

8-K - Current report
Sep 09, 2020

Major Issues Report

8-K - Current report